Home/Evecxia Therapeutics/Jennifer Hart, MS
JH

Jennifer Hart, MS

Executive Director, Operations

Evecxia Therapeutics

Evecxia Therapeutics Pipeline

DrugIndicationPhase
EVX-101 (5-HTP-based therapy)Major Depressive Disorder (MDD) - Adjunctive TreatmentPre-clinical